Zhonghui Bio-B (2627.HK) Skyrockets Over 170% in Gray Market Trading
3 week ago / Read about 0 minute
Author:小编   

Shares of Zhonghui Bio-B witnessed an astonishing surge of over 170% in Futu's gray market trading, reaching a quoted price of HK$35.16. Dedicated to the research, development, manufacturing, and commercialization of human vaccines, the company boasts a portfolio of core products, encompassing the already-marketed quadrivalent influenza virus subunit vaccine and the ongoing research into a freeze-dried human rabies vaccine.